Who invested in Veracyte?
Veracyte's investors include Kleiner Perkins Caufield & Byers, Domain Associates, Versant Ventures, TPG and GE Ventures, and 1 more on record.
United States · Series C startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$71Mraised across 3 rounds since 2010, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.com
From a historical funding record
Reported by onbiovc.comSEC filing: $9.3M sold, first sale Jun 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Veracyte's investors include Kleiner Perkins Caufield & Byers, Domain Associates, Versant Ventures, TPG and GE Ventures, and 1 more on record.
Veracyte has raised $71M across 3 rounds since 2010.
Veracyte's most recent round was a Series C of $28M in Jun 2013.
Its most recent round, $28M in Jun 2013, is also its largest on record.
Veracyte's first round on record, in Jun 2010, was backed by Kleiner Perkins Caufield & Byers, Versant Ventures and Domain Associates and 1 others.
Veracyte's latest named round is a Series C, in Jun 2013.
Veracyte is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.